Currently Partner of HealthCap. Previously worked with Business Development at Merck Serono and Research & Development at Novo Nordisk A/S. Specialties: Precision Medicine, Rare diseases and Orphan Drugs, Oncology, Hematology, Genetic Medicine, Neurodegenerative and Inflammatory Diseases, Corporate Strategy, Business Development, M&A and Venture Capital.
Board Member at Hemab Therapeutics
Doctor of Medicine - MD